Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
478 participants
OBSERVATIONAL
2018-07-27
2018-11-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our study aims to determine the incidence of IPA in a large multicenter cohort and to identify risk factors for IPA in these patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nosocomial Bacterial and Fungal Chest Infections in Cirrhotic Patients
NCT03413293
Staging Candidiasis in ICU Patients
NCT01322698
Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France
NCT04420286
Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU
NCT04368221
Impact of Dedicated Hygienist Staff on the Occurrence of Intensive Care Unit -Aquired Bloodstream Infections
NCT02891902
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admission to one of the participating sites
Exclusion Criteria
* patients with invasive pulmonary aspergillosis prior to intensive care admission
* consent withdraw
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Brest
Brest, , France
CHR
Morlaix, , France
CHU de NANTES
Nantes, , France
CHU de Rennes
Rennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASPERGIGRIPP (29BRC18.0069)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.